INTELLIOSMOTICS

Welcome to the Brand page for “INTELLIOSMOTICS”, which is offered here for Drug delivery systems, controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; drug delivery systems, controlled timed release and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations for humans; pharmaceutical preparations for humans incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;intelligent osmotics;research and development services for others in the pharmaceutical sciences, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;.

Its status is currently believed to be active. Its class is unavailable. “INTELLIOSMOTICS” is believed to be currently owned by “Intellipharmaceutics Corp.”

Owner:
INTELLIPHARMACEUTICS CORP.
Owner Details
Description:
Drug delivery systems, controlled timed release and/or targeted release pharmaceutical compositions provided as an integral component of pharmaceutical preparations for humans; Drug delivery systems, controlled timed release and/or targeted release pharmaceutical compositions, in the nature of oral solid dose tablets or capsules, provided as an integral component of pharmaceutical preparations for humans; Pharmaceutical preparations for humans incorporating controlled timed release and/or targeted release pharmaceutical compositions in the nature of drug delivery systems as an integral component, preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis;INTELLIGENT OSMOTICS;Research and development services for others in the pharmaceutical sciences, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations;
Categories: DRUG DELIVERY SYSTEMS